Abstract
Background
Left ventricular mobile thrombi carry high risk of embolism and need early treatment in which the appropriate treatment is still contraversial. Because most patients with mobile thrombi have low ejection fraction and also accompanying heart failure symptoms, desicion of surgical treatment is not always easy and thus effective medical treatment is crucial.
Method
In this paper we present, treatment and follow-up of seven patients with mobile thrombi who underwent fibrinolytic treatment between 2002 and 2006.
Results
In four cases, mobile thrombi disappeared completely while echocardiographically regressed to lower size with decreased mobility in the other three patients. On 6th month follow-up, complete lysis of the thrombi in six patients was observed with warfarin treatment. No major complications were seen in the patients.
Conclusion
In case of mobile left ventricular thrombi with concomitant low ejection fraction and heart failure fibrinolytic treatment might be a therapeutic option.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Falk RH, Foster E, Coats MH (1992) Ventricular thrombi and thromboembolism in dilated cardiomypathy. A prospective follow-up study. Am Heart J 123:136–142
Barbera S, Hillis LD (1999) Echocardiographic recognition of left ventricular mural thrombus. Echocardiography 16:289–295
Haugland JM, Asinger RW, Mikell FL, Elsperger J, Hodges M (1984) Embolic potential of left ventricular thrombi detected by two-dimensional echocardiography. Circulation 70:588–598
Kremer P, Fiebig R, Tilsner V, Bleifeld W, Mathey DG (1985) Lysis of left ventricular thrombi with urokinase. Circulation 72:112–118
Mathey DG, Siglow V, Kremer P, Schofer J, Tilsner V (1988) Lysis therapy for left ventricular thrombi. Dtsch Med Wochenschr 113:1271–1214
Keren A, Goldberg S, Gottlieb S et al (1990) Natural history of left ventricular thrombi: their appearance and resolution in the post hospitalization period of acute myocardial infarction. J Am Coll Cardiol 15:790–800
Krogmann ON, von Kries R, Rammos S, Kramer H, Bourgeois M (1991) Left ventricular thrombus in a 2-year-old boy with cardiomyopathy: lysis with recombinant tissue-type plasminogen activator. Eur J Pediatr 150:829–831
Kemennu L, Riggs TW (1992) Tissue plasminogen activator lysis of a right ventricular thrombus. Am Heart J 123:1057–1058
Yeh KH, Hung KC, Lin FC, Yeh SJ, Wu D (2000) Successful lysis of right and left heart thrombus by tissue plasminogen activator. Catheter Cardiovasc Intervent 49:91–96
Heik SC, Kupper W, Ham C, Bleifeld W, Koscyhk DH, Waters D (1994) Efficacy of high dose intravenous heparin for treatment of left ventricular thrombi with high embolic risk. J Am Coll Cardiol 24:1305–1309
Meurin P, Tabet JY, Renaud N, Weber H, Grosdemouge A, Bourmeyan C et al (2005) Treatment of left ventricular thrombi with a low molecular weight heparin. Int J Cardiol 98:319–323
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sari, I., Davutoğlu, V., Soydinc, S. et al. Fibrinolytic treatment in left ventricular mobile thrombi with low ejection fraction: results and follow-up of seven cases. J Thromb Thrombolysis 25, 293–296 (2008). https://doi.org/10.1007/s11239-007-0043-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-007-0043-7